2022 Startup Spotlight Presenters
BIMINI Biotech is a preclinical stage company developing first-in-class small molecule therapeutics for lymphomas and leukemias. Our approach is based on pioneering research by Institute of Oncology Research (CH) and Bar-Ilan University (IL). Our molecules target Wiskott Aldrich Syndrome Protein - an actin nucleation related protein expressed exclusively in hematological cells. We have both an agonist and antagonist for this target, and early PoC data for the leads is extremely promising.